feed,title,long_url,short_url
MedRxiv,H2 inhalation therapy in patients with moderate Covid 19 (H2 COVID) : a prospective ascending-dose phase 1 clinical trial,https://medrxiv.org/cgi/content/short/2024.03.15.24304071v1?rss=1,https://da.gd/fDdb2
